JPY 2639.0
(-1.35%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 4.57 Billion JPY | 4.36% |
2023 | 4.38 Billion JPY | 11.71% |
2022 | 3.92 Billion JPY | 2.52% |
2021 | 3.82 Billion JPY | -11.46% |
2020 | 4.32 Billion JPY | 6.56% |
2019 | 4.05 Billion JPY | 2.2% |
2018 | 3.97 Billion JPY | 19.18% |
2017 | 3.33 Billion JPY | 17.15% |
2016 | 2.84 Billion JPY | 7.44% |
2015 | 2.64 Billion JPY | 3.69% |
2014 | 2.55 Billion JPY | 4.04% |
2013 | 2.45 Billion JPY | 0.61% |
2012 | 2.43 Billion JPY | 0.06% |
2011 | 2.43 Billion JPY | 3.96% |
2010 | 2.34 Billion JPY | 3.48% |
2009 | 2.26 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 1.13 Billion JPY | 0.28% |
2024 Q4 | 1.2 Billion JPY | 6.08% |
2024 Q2 | 1.12 Billion JPY | 1.28% |
2024 Q1 | 1.11 Billion JPY | -8.06% |
2023 Q1 | 1.06 Billion JPY | 1.54% |
2023 Q4 | 1.21 Billion JPY | 14.45% |
2023 FY | 4.38 Billion JPY | 11.71% |
2023 Q2 | 1.04 Billion JPY | -1.84% |
2023 Q3 | 1.05 Billion JPY | 1.17% |
2022 Q2 | 976.91 Million JPY | 2.42% |
2022 Q4 | 1.05 Billion JPY | 11.23% |
2022 Q3 | 944.42 Million JPY | -3.33% |
2022 Q1 | 953.83 Million JPY | 0.94% |
2022 FY | 3.92 Billion JPY | 2.52% |
2021 Q3 | 955.48 Million JPY | 2.52% |
2021 Q4 | 944.98 Million JPY | -1.1% |
2021 FY | 3.82 Billion JPY | -11.46% |
2021 Q1 | 996.79 Million JPY | -10.37% |
2021 Q2 | 931.99 Million JPY | -6.5% |
2020 Q2 | 1 Billion JPY | -5.75% |
2020 Q3 | 1.13 Billion JPY | 12.68% |
2020 FY | 4.32 Billion JPY | 6.56% |
2020 Q1 | 1.06 Billion JPY | -0.1% |
2020 Q4 | 1.11 Billion JPY | -2.08% |
2019 FY | 4.05 Billion JPY | 2.2% |
2019 Q3 | 992.98 Million JPY | -0.62% |
2019 Q4 | 1.07 Billion JPY | 7.81% |
2019 Q1 | 996.16 Million JPY | 0.47% |
2019 Q2 | 999.16 Million JPY | 0.3% |
2018 Q3 | 988.94 Million JPY | -35.88% |
2018 FY | 3.97 Billion JPY | 19.18% |
2018 Q2 | 1.54 Billion JPY | 243.96% |
2018 Q1 | 448.43 Million JPY | -80.76% |
2018 Q4 | 991.5 Million JPY | 0.26% |
2017 Q4 | 2.33 Billion JPY | 745.6% |
2017 Q3 | 275.68 Million JPY | -28.24% |
2017 Q1 | 341.23 Million JPY | -82.11% |
2017 Q2 | 384.17 Million JPY | 12.58% |
2017 FY | 3.33 Billion JPY | 17.15% |
2016 Q2 | 263.11 Million JPY | -19.74% |
2016 FY | 2.84 Billion JPY | 7.44% |
2016 Q1 | 327.82 Million JPY | -81.58% |
2016 Q3 | 345.51 Million JPY | 31.32% |
2016 Q4 | 1.9 Billion JPY | 452.19% |
2015 Q4 | 1.77 Billion JPY | 470.07% |
2015 Q3 | 312.2 Million JPY | 30.66% |
2015 Q2 | 238.93 Million JPY | -24.51% |
2015 Q1 | 316.53 Million JPY | -81.56% |
2015 FY | 2.64 Billion JPY | 3.69% |
2014 FY | 2.55 Billion JPY | 4.04% |
2014 Q4 | 1.71 Billion JPY | 500.22% |
2014 Q3 | 285.98 Million JPY | 21.37% |
2014 Q2 | 235.63 Million JPY | -25.23% |
2014 Q1 | 315.15 Million JPY | -80.73% |
2013 Q4 | 1.63 Billion JPY | 440.9% |
2013 Q2 | 219.97 Million JPY | -25.89% |
2013 Q1 | 296.8 Million JPY | -81.74% |
2013 Q3 | 302.28 Million JPY | 37.42% |
2013 FY | 2.45 Billion JPY | 0.61% |
2012 Q4 | 1.62 Billion JPY | 444.76% |
2012 Q3 | 298.3 Million JPY | 30.55% |
2012 Q1 | 287.41 Million JPY | -82.18% |
2012 Q2 | 228.5 Million JPY | -20.5% |
2012 FY | 2.43 Billion JPY | 0.06% |
2011 FY | 2.43 Billion JPY | 3.96% |
2011 Q4 | 1.61 Billion JPY | 437.52% |
2011 Q2 | 235.65 Million JPY | -18.92% |
2011 Q1 | 290.65 Million JPY | -80.97% |
2011 Q3 | 300.09 Million JPY | 27.35% |
2010 Q3 | 285.11 Million JPY | 0.0% |
2010 FY | 2.34 Billion JPY | 3.48% |
2010 Q4 | 1.52 Billion JPY | 435.78% |
2009 FY | 2.26 Billion JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Kitanotatsujin Corporation | 9.38 Billion JPY | 51.227% |
Euglena Co., Ltd. | 34.45 Billion JPY | 86.716% |
BEAUTY GARAGE Inc. | 5.8 Billion JPY | 21.099% |
Axas Holdings Co.,Ltd. | 3 Billion JPY | -52.526% |
C.I. Medical Co.,Ltd. | 9 Billion JPY | 49.184% |
Kao Corporation | 438.95 Billion JPY | 98.957% |
Niitaka Co., Ltd. | 6.65 Billion JPY | 31.282% |
Rohto Pharmaceutical Co.,Ltd. | 117.23 Billion JPY | 96.096% |
Shiseido Company, Limited | 696.62 Billion JPY | 99.343% |
Lion Corporation | 160.09 Billion JPY | 97.141% |
Mandom Corporation | 29.51 Billion JPY | 84.492% |
Ivy Cosmetics Corporation | 1.72 Billion JPY | -165.245% |
Milbon Co., Ltd. | 24 Billion JPY | 80.931% |
Nippon Shikizai, Inc. | 2.31 Billion JPY | -97.965% |
Fancl Corporation | 61.61 Billion JPY | 92.573% |
KOSÉ Corporation | 189.85 Billion JPY | 97.59% |
Cota Co., Ltd. | 4.25 Billion JPY | -7.602% |
HABA Laboratories,Inc. | 8.21 Billion JPY | 44.283% |
C'bon Cosmetics Co.,Ltd. | 6.37 Billion JPY | 28.162% |
Pola Orbis Holdings Inc. | 119.68 Billion JPY | 96.176% |
Noevir Holdings Co., Ltd. | 31.54 Billion JPY | 85.49% |
Adjuvant Holdings Co.,Ltd. | 2.86 Billion JPY | -59.924% |
Almado, Inc. | 4.11 Billion JPY | -11.335% |
I-ne CO., LTD. | 17.86 Billion JPY | 74.383% |
Premier Anti-Aging Co., Ltd. | 15.96 Billion JPY | 71.327% |
Liberta Co.,Ltd. | 2.68 Billion JPY | -70.692% |
AXXZIA Inc. | 8.57 Billion JPY | 46.614% |
S.T. Corporation | 15.07 Billion JPY | 69.638% |
Kobayashi Pharmaceutical Co., Ltd. | 70.59 Billion JPY | 93.517% |
Earth Corporation | 57.25 Billion JPY | 92.007% |
Sagami Rubber Industries Co., Ltd. | 1.57 Billion JPY | -191.355% |
Asahi Eito Holdings Co.,Ltd. | 1.29 Billion JPY | -252.453% |
Ya-Man Ltd. | 18.49 Billion JPY | 75.26% |
MTG Co., Ltd. | 33.26 Billion JPY | 86.241% |
SHOBIDO Corporation | 4.5 Billion JPY | -1.69% |
Artnature Inc. | 25.01 Billion JPY | 81.705% |
Pigeon Corporation | 34.72 Billion JPY | 86.822% |
Unicharm Corporation | 351.52 Billion JPY | 98.698% |
Paltac Corporation | 53.06 Billion JPY | 91.375% |
CB GROUP MANAGEMENT Co., Ltd. | 13.78 Billion JPY | 66.801% |